Home

Editor Bewältigung Zigarette reuters teva erkunden Liebhaber Meyella

California judge rules for Israeli Teva in major opioid lawsuit - The  Jerusalem Post
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post

Teva to proceed with Rimsa breach of contract suit after ruling
Teva to proceed with Rimsa breach of contract suit after ruling

Reuters: Teva to pay US government $519 million over foreign bribery  charges - Dec. 22, 2016 | KyivPost | KyivPost - Ukraine's Global Voice
Reuters: Teva to pay US government $519 million over foreign bribery charges - Dec. 22, 2016 | KyivPost | KyivPost - Ukraine's Global Voice

AstraZeneca's CEO Soriot to join Israeli drugs company Teva: report By  Reuters
AstraZeneca's CEO Soriot to join Israeli drugs company Teva: report By Reuters

Teva Prices EpiPen Generic at $300
Teva Prices EpiPen Generic at $300

Teva under police investigation in home market of Israel | Financial Times
Teva under police investigation in home market of Israel | Financial Times

Teva buys Anda for $500 million - ISRAEL21c
Teva buys Anda for $500 million - ISRAEL21c

A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New  York Times
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times

Shlomo Yanai, Teva's president and chief executive, speaks to the media  during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical  Industries, the world's largest generic drugmaker, reported higher quarterly
Shlomo Yanai, Teva's president and chief executive, speaks to the media during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical Industries, the world's largest generic drugmaker, reported higher quarterly

Flags of Croatia's pharmaceutical company Pliva owned by Teva  Pharmaceutical Industries are seen in front of the company's building in  Zagreb March 18, 2010. Pliva was Croatia's biggest drugs firm in the
Flags of Croatia's pharmaceutical company Pliva owned by Teva Pharmaceutical Industries are seen in front of the company's building in Zagreb March 18, 2010. Pliva was Croatia's biggest drugs firm in the

A woman passes by the logo of Croatia's pharmaceutical company Pliva owned  by Israeli Teva in Zagreb March 18, 2010. Pliva was Croatia's biggest drugs  firm in the 1990s and traded on
A woman passes by the logo of Croatia's pharmaceutical company Pliva owned by Israeli Teva in Zagreb March 18, 2010. Pliva was Croatia's biggest drugs firm in the 1990s and traded on

Reuters: U.S. states accuse Teva of price-fixing • Rx|X Consulting
Reuters: U.S. states accuse Teva of price-fixing • Rx|X Consulting

The logo of Croatia's pharmaceutical company Pliva owned by Teva  Pharmaceutical Industries is seen at the top of the company's building in  Zagreb March 18, 2010. Pliva was Croatia's biggest drugs firm
The logo of Croatia's pharmaceutical company Pliva owned by Teva Pharmaceutical Industries is seen at the top of the company's building in Zagreb March 18, 2010. Pliva was Croatia's biggest drugs firm

Teva chief executive Shlomo Yanai speaks during a tour at the company's new  distribution centre in the central Israeli town of Shoham March 1, 2011.  Teva Pharmaceutical Industries, the world's largest generics
Teva chief executive Shlomo Yanai speaks during a tour at the company's new distribution centre in the central Israeli town of Shoham March 1, 2011. Teva Pharmaceutical Industries, the world's largest generics

Teva sees higher margins, lower debt from restructuring | Financial Times
Teva sees higher margins, lower debt from restructuring | Financial Times

Teva Pharm to Close Plant in Israel After No Buyer Found
Teva Pharm to Close Plant in Israel After No Buyer Found

The logo of Croatia's pharmaceutical company Pliva owned by Teva  Pharmaceutical Industries is seen in front of the company's building in  Zagreb March 18, 2010. Pliva was Croatia's biggest drugs firm in the 1990s  and traded on the London Stock ...
The logo of Croatia's pharmaceutical company Pliva owned by Teva Pharmaceutical Industries is seen in front of the company's building in Zagreb March 18, 2010. Pliva was Croatia's biggest drugs firm in the 1990s and traded on the London Stock ...

Teva, Amgen end dispute over generic Cinacalcet HCl tablets By Reuters
Teva, Amgen end dispute over generic Cinacalcet HCl tablets By Reuters

Teva Pharm Expects About 25 Percent of EpiPen Market by Year End
Teva Pharm Expects About 25 Percent of EpiPen Market by Year End

Levinstein's purchase of Teva's Jerusalem plant in doubt - Globes
Levinstein's purchase of Teva's Jerusalem plant in doubt - Globes

The logo of Teva Pharmaceutical Industries is seen on a part of their  building in Jerusalem December 14, 2017. REUTERS/Ammar Awad Stock Photo -  Alamy
The logo of Teva Pharmaceutical Industries is seen on a part of their building in Jerusalem December 14, 2017. REUTERS/Ammar Awad Stock Photo - Alamy

CVS Picks Migraine Drugs by Teva, Eli Lilly, Snubs Amgen, Reuters Reports |  Ctech
CVS Picks Migraine Drugs by Teva, Eli Lilly, Snubs Amgen, Reuters Reports | Ctech

A sign bearing the logo of Teva Pharmaceutical Industries is seen in its  Jerusalem oral solid dosage plant (OSD) December 21, 2011. Israel-based Teva  is the world's leading generic drugmaker. REUTERS/Ronen Zvulun (
A sign bearing the logo of Teva Pharmaceutical Industries is seen in its Jerusalem oral solid dosage plant (OSD) December 21, 2011. Israel-based Teva is the world's leading generic drugmaker. REUTERS/Ronen Zvulun (

Teva Pharmaceutical Industries' Jerusalem oral solid dosage plant (OSD) is  seen December 21, 2011. Israel-based Teva is the world's leading generic  drugmaker. REUTERS/Ronen Zvulun (JERUSALEM - Tags: BUSINESS DRUGS SOCIETY  Stock Photo -
Teva Pharmaceutical Industries' Jerusalem oral solid dosage plant (OSD) is seen December 21, 2011. Israel-based Teva is the world's leading generic drugmaker. REUTERS/Ronen Zvulun (JERUSALEM - Tags: BUSINESS DRUGS SOCIETY Stock Photo -

GSK's $235 million verdict revived against Teva, again | Reuters
GSK's $235 million verdict revived against Teva, again | Reuters